Rallybio Corporation (RLYB) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Rallybio Corporation (RLYB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $77.0M, listed on NASDAQ, employing roughly 15 people, carrying a beta of -1.10 to the broader market. Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Led by Stephen Uden, public since 2021-07-29.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for RLYB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →